Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, Jan. 17, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Vistagen...
-
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing ...
-
LOS ANGELES, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Vistagen Therapeutics, Inc., (“Vistagen” or the "Company") (NASDAQ: VTGN) investors off a class action on behalf of...
-
Vistagen Therapeutics Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
-
the Company is providing the following administrative updates to ensure it remains compliant with relevant securities regulations.
-
HINGHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the fourth quarter and the year ended December 31,...
-
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ: VALU) announced today that its Board of Directors declared on January 16, 2026 a quarterly cash dividend of $0.325 per common...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Vistagen To Contact Him Directly To Discuss Their Options If you purchased or acquired...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jayud (JYD) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
-
HOUSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Dr. Michael Lebow, a nationally recognized board-certified vascular surgeon, announces the launch of the Dr. Michael Lebow Healthcare Made-Easy Grant, a...